Is Thymosin Beta-4 FDA approved?
Current U.S. status for Thymosin Beta-4: No FDA-approved thymosin beta-4 drug product identified in the August 2026 source snapshot.
DIRECT ANSWER
Thymosin Beta-4 FDA status.
Current U.S. status for Thymosin Beta-4: No FDA-approved thymosin beta-4 drug product identified in the August 2026 source snapshot.
Reviewed August 8, 2026. Each statement links to its evidence record, followed by the primary and official sources used for this answer.
No FDA-approved thymosin beta-4 drug product identified in the August 2026 source snapshot.
Open evidence recordThymosin beta-4 has early human development work and extensive preclinical biology, but that record does not establish routine systemic recovery use or equivalence to TB-500 products.
Open evidence recordApproval, evidence maturity, commercial access, and sport status answer different questions. The full record keeps them separate.
Open evidence recordPRIMARY & OFFICIAL SOURCES
Sources for this answer.
3 source records, with duplicates removed.